Search

everythinglearnresearchcommunity

for

Search:↓

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Flutamide rarely causes liver toxicity in prostate cancer patients.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

A woman's high testosterone levels were caused by a rare ovarian tumor, not the initially diagnosed condition.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The Hairless gene is crucial for healthy skin and hair growth.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The hr gene is crucial for skin and hair health, with mutations causing hair disorders.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Tamoxifen effectively treats gynecomastia without causing impotence.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.